Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Adaptive introgression of anticoagulant rodent poison resistance by hybridization between old world mice.

Song Y, Endepols S, Klemann N, Richter D, Matuschka FR, Shih CH, Nachman MW, Kohn MH.

Curr Biol. 2011 Aug 9;21(15):1296-301. doi: 10.1016/j.cub.2011.06.043. Epub 2011 Jul 21.

2.

Study of the efficiency of anticoagulant rodenticides to control Mus musculus domesticus introgressed with Mus spretus Vkorc1.

Goulois J, Hascoët C, Dorani K, Besse S, Legros L, Benoit E, Lattard V.

Pest Manag Sci. 2017 Feb;73(2):325-331. doi: 10.1002/ps.4319. Epub 2016 Jun 23.

PMID:
27196872
3.

Vkorc1 variation in house mice during warfarin and difenacoum field trials.

Endepols S, Klemann N, Song Y, Kohn MH.

Pest Manag Sci. 2013 Mar;69(3):409-13. doi: 10.1002/ps.3306. Epub 2012 Apr 23.

PMID:
22528807
4.

Interspecific introgressive origin of genomic diversity in the house mouse.

Liu KJ, Steinberg E, Yozzo A, Song Y, Kohn MH, Nakhleh L.

Proc Natl Acad Sci U S A. 2015 Jan 6;112(1):196-201. doi: 10.1073/pnas.1406298111. Epub 2014 Dec 15.

5.

The genetic basis of resistance to anticoagulants in rodents.

Pelz HJ, Rost S, Hünerberg M, Fregin A, Heiberg AC, Baert K, MacNicoll AD, Prescott CV, Walker AS, Oldenburg J, Müller CR.

Genetics. 2005 Aug;170(4):1839-47. Epub 2005 May 6.

6.

Adaptative evolution of the Vkorc1 gene in Mus musculus domesticus is influenced by the selective pressure of anticoagulant rodenticides.

Goulois J, Lambert V, Legros L, Benoit E, Lattard V.

Ecol Evol. 2017 Mar 21;7(8):2767-2776. doi: 10.1002/ece3.2829. eCollection 2017 Apr.

7.

Consequences of the Y139F Vkorc1 mutation on resistance to AVKs: in-vivo investigation in a 7th generation of congenic Y139F strain of rats.

Grandemange A, Kohn MH, Lasseur R, Longin-Sauvageon C, Berny P, Benoit E.

Pharmacogenet Genomics. 2009 Oct;19(10):742-50. doi: 10.1097/FPC.0b013e32832ee55b.

8.

Adaptive introgression: the seeds of resistance.

Rieseberg L.

Curr Biol. 2011 Aug 9;21(15):R581-3. doi: 10.1016/j.cub.2011.06.038.

9.

Distribution and frequency of VKORC1 sequence variants conferring resistance to anticoagulants in Mus musculus.

Pelz HJ, Rost S, Müller E, Esther A, Ulrich RG, Müller CR.

Pest Manag Sci. 2012 Feb;68(2):254-9. doi: 10.1002/ps.2254. Epub 2011 Sep 6.

PMID:
21898757
10.

[Vitamin K epoxide reductase: Fresh blood for oral anticoagulant therapies].

Loriot MA, Beaune P.

Rev Med Interne. 2006 Dec;27(12):979-82. Epub 2006 Oct 11. Review. French.

PMID:
17070618
11.

Polymorphism in vkorc1 Gene of Natal Multimammate Mice, Mastomys natalensis, in Tanzania.

Gryseels S, Leirs H, Makundi R, Goüy de Bellocq J.

J Hered. 2015 Sep-Oct;106(5):637-43. doi: 10.1093/jhered/esv054. Epub 2015 Jul 29.

PMID:
26223233
13.
14.

Biochemical basis of warfarin and bromadiolone resistance in the house mouse, Mus musculus domesticus.

Misenheimer TM, Lund M, Baker EM, Suttie JW.

Biochem Pharmacol. 1994 Feb 11;47(4):673-8.

PMID:
8129744
15.

Warfarin resistance in a French strain of rats.

Lasseur R, Longin-Sauvageon C, Videmann B, Billeret M, Berny P, Benoit E.

J Biochem Mol Toxicol. 2005;19(6):379-85.

PMID:
16421894
16.

Positive selection in the chromosome 16 VKORC1 genomic region has contributed to the variability of anticoagulant response in humans.

Patillon B, Luisi P, Blanché H, Patin E, Cann HM, Génin E, Sabbagh A.

PLoS One. 2012;7(12):e53049. doi: 10.1371/journal.pone.0053049. Epub 2012 Dec 28.

17.

Novel mutations in the VKORC1 gene of wild rats and mice--a response to 50 years of selection pressure by warfarin?

Rost S, Pelz HJ, Menzel S, MacNicoll AD, León V, Song KJ, Jäkel T, Oldenburg J, Müller CR.

BMC Genet. 2009 Feb 6;10:4. doi: 10.1186/1471-2156-10-4.

18.

Pesticide resistance in wild mammals--mechanisms of anticoagulant resistance in wild rodents.

Ishizuka M, Tanikawa T, Tanaka KD, Heewon M, Okajima F, Sakamoto KQ, Fujita S.

J Toxicol Sci. 2008 Aug;33(3):283-91.

19.

Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2.

Rost S, Fregin A, Ivaskevicius V, Conzelmann E, Hörtnagel K, Pelz HJ, Lappegard K, Seifried E, Scharrer I, Tuddenham EG, Müller CR, Strom TM, Oldenburg J.

Nature. 2004 Feb 5;427(6974):537-41.

PMID:
14765194
20.

A vitamin K epoxide reductase-oxidase complex gene polymorphism (-1639G>A) and interindividual variability in the dose-effect of vitamin K antagonists.

Stepien E, Branicka A, Ciesla-Dul M, Undas A.

J Appl Genet. 2009;50(4):399-403. doi: 10.1007/BF03195700.

PMID:
19875892

Supplemental Content

Support Center